Kymera Therapeutics (KYMR) Stock Chart & Stock Price History $47.33 -1.06 (-2.19%) As of 03:28 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kymera Therapeutics Stock Price Performance The Kymera Therapeutics (KYMR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 36.79%, with a year-to-date return of 17.65%. In the past month, the stock has increased 47.12%, reflecting recent market activity. As of the latest close, Kymera Therapeutics traded at $48.39 with a market cap of $3.15 billion and volume of 700,979 shares. Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.61%1 Month Performance+47.12%3 Month Performance+34.84%Year-To-Date Performance+17.65%1 Year Performance+36.79% KYMR Stock Chart for Thursday, June, 12, 2025 KYMR Chart by TradingView Kymera Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$48.60$48.39-0.43%$50.27$47.94700,979 shs$3.15 billion06/10/2025$47.16$48.60+3.05%$49.02$47.18907,027 shs$3.16 billion06/09/2025$47.62$47.16-0.97%$47.94$45.80847,867 shs$3.07 billion06/06/2025$47.66$47.62-0.08%$49.98$47.03986,878 shs$3.10 billion06/05/2025$44.26$47.66+7.68%$47.95$43.091.32 million shs$3.10 billion06/04/2025$43.58$44.26+1.56%$45.45$42.831.14 million shs$2.88 billion06/03/2025$43.13$43.58+1.04%$49.35$43.123.52 million shs$2.84 billion06/02/2025$29.46$43.13+46.40%$43.97$36.866.31 million shs$2.81 billion05/30/2025$30.25$29.46-2.61%$29.96$28.50649,895 shs$1.92 billion05/29/2025$28.80$30.25+5.03%$30.28$28.50936,062 shs$1.97 billion Get the Latest News and Ratings for KYMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$28.14$28.80+2.35%$30.20$28.331.37 million shs$1.88 billion05/27/2025$29.49$28.14-4.58%$30.25$28.06617,061 shs$1.83 billion05/26/2025$29.49$29.49$29.79$29.15352,793 shs$1.92 billion05/23/2025$30.17$29.49-2.25%$29.79$29.15352,793 shs$1.92 billion05/22/2025$30.13$30.17+0.13%$30.78$29.84386,402 shs$1.96 billion05/21/2025$31.44$30.13-4.17%$31.30$29.53572,983 shs$1.96 billion05/20/2025$30.20$31.44+4.11%$31.47$29.85462,381 shs$2.05 billion05/19/2025$30.25$30.20-0.17%$30.91$29.15557,977 shs$1.97 billion05/16/2025$30.02$30.25+0.77%$30.42$29.30440,383 shs$1.97 billion05/15/2025$29.75$30.02+0.91%$30.04$29.31452,604 shs$1.95 billion05/14/2025$31.14$29.75-4.46%$31.64$29.59383,256 shs$1.94 billion05/13/2025$32.17$31.14-3.20%$32.38$30.46442,700 shs$2.03 billion05/12/2025$30.07$32.17+6.98%$33.71$30.51658,282 shs$2.09 billion Related Companies ASND Stock Chart MRNA Stock Chart VTRS Stock Chart QGEN Stock Chart BPMC Stock Chart ROIV Stock Chart RVMD Stock Chart VRNA Stock Chart BBIO Stock Chart ELAN Stock Chart Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYMR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KYMR Stock Free KYMR Stock Alerts